Central Pacific Bank - Trust Division’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $984K | Buy |
3,018
+365
| +14% | +$119K | 0.13% | 169 |
|
|
2025
Q1 | $716K | Buy |
2,653
+1,648
| +164% | +$445K | 0.1% | 204 |
|
|
2024
Q4 | $236K | Sell |
1,005
-20
| -2% | -$4.71K | 0.03% | 417 |
|
|
2024
Q3 | $282K | Sell |
1,025
-25
| -2% | -$6.88K | 0.04% | 398 |
|
|
2024
Q2 | $255K | Hold |
1,050
| – | – | 0.03% | 487 |
|
|
2024
Q1 | $161K | Buy |
+1,050
| New | +$161K | 0.02% | 594 |
|